Literature DB >> 20046952

Correcting Instrumental Variables Estimators for Systematic Measurement Error.

Stijn Vansteelandt1, Manoochehr Babanezhad, Els Goetghebeur.   

Abstract

Instrumental variables (IV) estimators are well established to correct for measurement error on exposure in a broad range of fields. In a distinct prominent stream of research IV's are becoming increasingly popular for estimating causal effects of exposure on outcome since they allow for unmeasured confounders which are hard to avoid. Because many causal questions emerge from data which suffer severe measurement error problems, we combine both IV approaches in this article to correct IV-based causal effect estimators in linear (structural mean) models for possibly systematic measurement error on the exposure. The estimators rely on the presence of a baseline measurement which is associated with the observed exposure and known not to modify the target effect. Simulation studies and the analysis of a small blood pressure reduction trial (n = 105) with treatment noncompliance confirm the adequate performance of our estimators in finite samples. Our results also demonstrate that incorporating limited prior knowledge about a weakly identified parameter (such as the error mean) in a frequentist analysis can yield substantial improvements.

Entities:  

Year:  2009        PMID: 20046952      PMCID: PMC2743431     

Source DB:  PubMed          Journal:  Stat Sin        ISSN: 1017-0405            Impact factor:   1.261


  15 in total

1.  The problem of measurement error in modelling the effect of compliance in a randomized trial.

Authors:  G Dunn
Journal:  Stat Med       Date:  1999-11-15       Impact factor: 2.373

2.  An introduction to instrumental variables for epidemiologists.

Authors:  S Greenland
Journal:  Int J Epidemiol       Date:  2000-08       Impact factor: 7.196

3.  Sense and sensitivity when correcting for observed exposures in randomized clinical trials.

Authors:  S Vansteelandt; E Goetghebeur
Journal:  Stat Med       Date:  2005-01-30       Impact factor: 2.373

4.  Structural mean models for compliance analysis in randomized clinical trials and the impact of errors on measures of exposure.

Authors:  Els Goetghebeur; Vansteelandt Stijn
Journal:  Stat Methods Med Res       Date:  2005-08       Impact factor: 3.021

5.  Instruments for causal inference: an epidemiologist's dream?

Authors:  Miguel A Hernán; James M Robins
Journal:  Epidemiology       Date:  2006-07       Impact factor: 4.822

6.  Mediation analysis via potential outcomes models.

Authors:  Jeffrey M Albert
Journal:  Stat Med       Date:  2008-04-15       Impact factor: 2.373

Review 7.  Mendelian randomization as an instrumental variable approach to causal inference.

Authors:  Vanessa Didelez; Nuala Sheehan
Journal:  Stat Methods Med Res       Date:  2007-08       Impact factor: 3.021

8.  Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.

Authors:  Lut Van Damme; Gita Ramjee; Michel Alary; Bea Vuylsteke; Verapol Chandeying; Helen Rees; Pachara Sirivongrangson; Léonard Mukenge-Tshibaka; Virginie Ettiègne-Traoré; Charn Uaheowitchai; Salim S Abdool Karim; Benoît Mâsse; Jos Perriëns; Marie Laga
Journal:  Lancet       Date:  2002-09-28       Impact factor: 79.321

9.  Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens.

Authors:  J Urquhart; E De Klerk
Journal:  Stat Med       Date:  1998-02-15       Impact factor: 2.373

10.  Homocysteine and stroke: evidence on a causal link from mendelian randomisation.

Authors:  Juan P Casas; Leonelo E Bautista; Liam Smeeth; Pankaj Sharma; Aroon D Hingorani
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

View more
  1 in total

1.  Adjusting the Effect of Integrating Antiretroviral Therapy and Tuberculosis Treatment on Mortality for Noncompliance: A Time-varying Instrumental Variables Analysis.

Authors:  Nonhlanhla Yende-Zuma; Henry Mwambi; Stijn Vansteelandt
Journal:  Epidemiology       Date:  2019-03       Impact factor: 4.822

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.